This method helped develop a new drug delivery system for treating neurodegenerative diseases by exposing macrophages to plasmid DNA (pDNA) with therapeutic proteins such as catalase or glial cell line-derived neurotrophic factor (GDNF). This evidence concerns the gene GDNF and neurodegenerative disease.